Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants

• Scott J C Pallett,
• Joseph Heskin,
• Elisabetta Groppelli,
• Andrea Mazzella,
• Luke S P Moore

Affiliations

Scott J C Pallett

Chelsea and Westminster Hospital NHS Foundation Trust, London SW10 9NH, UK; Centre of Defence Pathology, Royal Centre for Defence Medicine, Birmingham, UK; Infection Care Group, St George's University Hospitals NHS Foundation Trust, London, UK

Joseph Heskin

Chelsea and Westminster Hospital NHS Foundation Trust, London SW10 9NH, UK

Elisabetta Groppelli

Clinical Academic Group in Infection and Immunity, Institute for Infection and Immunity, St George's University of London, London, UK

Andrea Mazzella

Clinical Academic Group in Infection and Immunity, Institute for Infection and Immunity, St George's University of London, London, UK

Luke S P Moore

Chelsea and Westminster Hospital NHS Foundation Trust, London SW10 9NH, UK; Imperial College London, NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, London, UK; North West London Pathology, Imperial College Healthcare NHS Trust, London, UK